Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page
- Check5 days agoChange DetectedThe page now includes an explicit recruitment update 'No longer looking for participants' and adds user guidance sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The header 'Intervention/Treatment' is introduced (replacing 'Intervention / Treatment'), and a 'Revision: v3.6.0' tag appears alongside removal of 'Revision: v3.5.5'.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page's revision label has been updated from v3.5.4 to v3.5.5. This update represents a newer version of the page's revision history without modifying the study details or results.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating the page now reflects the latest revision. This change represents an update to the page version rather than any study data or content.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page’s footer/site revision tag was updated from **v3.5.2** to **v3.5.3**, indicating a general system release rather than a change to the clinical trial record.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded 'B-cell chronic lymphocytic leukemia' to the study's Conditions section.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.